Related Experiment Video
Updated: Jun 14, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Murine coronavirus delays expression of a subset of interferon-stimulated genes
Kristine M Rose1, Ruth Elliott, Luis Martínez-Sobrido
1Department of Microbiology, University of Pennsylvania, School of Medicine, 36th Street and Hamilton Walk, Philadelphia, PA 19104-6076, USA.
Abstract:
The importance of the type I interferon (IFN-I) system in limiting coronavirus replication and dissemination has been unequivocally demonstrated by rapid lethality following infection of mice lacking the alpha/beta IFN (IFN-alpha/beta) receptor with mouse hepatitis virus (MHV), a murine coronavirus. Interestingly, MHV has a cell-type-dependent ability to resist the antiviral effects of IFN-alpha/beta. In primary bone-marrow-derived macrophages and mouse embryonic fibroblasts, MHV replication was significantly reduced by the IFN-alpha/beta-induced antiviral state, whereas IFN treatment of cell lines (L2 and 293T) has only minor effects on replication (K. M. Rose and S. R. Weiss, Viruses 1:689-712, 2009). Replication of other RNA viruses, including Theiler's murine encephalitis virus (TMEV), vesicular stomatitis virus (VSV), Sindbis virus, Newcastle disease virus (NDV), and Sendai virus (SeV), was significantly inhibited in L2 cells treated with IFN-alpha/beta, and MHV had the ability to rescue only SeV replication. We present evidence that MHV infection can delay interferon-stimulated gene (ISG) induction mediated by both SeV and IFN-beta but only when MHV infection precedes SeV or IFN-beta exposure. Curiously, we observed no block in the well-defined IFN-beta signaling pathway that leads to STAT1-STAT2 phosphorylation and translocation to the nucleus in cultures infected with MHV. This observation suggests that MHV must inhibit an alternative IFN-induced pathway that is essential for early induction of ISGs. The ability of MHV to delay SeV-mediated ISG production may partially involve limiting the ability of IFN regulatory factor 3 (IRF-3) to function as a transcription factor. Transcription from an IRF-3-responsive promoter was partially inhibited by MHV; however, IRF-3 was transported to the nucleus and bound DNA in MHV-infected cells superinfected with SeV.
Insights
Mouse hepatitis virus (MHV) resists type I interferon (IFN-I) antiviral effects by delaying interferon-stimulated gene induction. MHV inhibits an alternative IFN-I pathway, not the main signaling cascade, impacting IRF-3 function.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Type I interferons (IFN-I) are crucial for controlling viral infections, including coronaviruses.
- Mouse hepatitis virus (MHV) exhibits cell-type-dependent resistance to IFN-I antiviral activity.
- Previous studies show MHV replication is inhibited by IFN-I in primary cells but less so in cell lines.
Purpose of the Study:
- To investigate the mechanisms by which MHV resists IFN-I-mediated antiviral responses.
- To determine if MHV interferes with interferon-stimulated gene (ISG) induction.
- To elucidate the specific IFN-I signaling pathways affected by MHV infection.
Main Methods:
- Infection of cell lines (L2, 293T) and primary cells (macrophages, fibroblasts) with MHV.
- Treatment with IFN-alpha/beta and superinfection with other RNA viruses (SeV, TMEV, VSV, NDV).
- Analysis of ISG induction, STAT1-STAT2 phosphorylation, nuclear translocation, and IRF-3 activity.
Main Results:
- MHV infection delays ISG induction triggered by SeV or IFN-beta when MHV infection precedes exposure.
- MHV does not block the canonical IFN-beta signaling pathway involving STAT1-STAT2 phosphorylation.
- MHV partially inhibits IRF-3-dependent transcription, suggesting interference with an alternative IFN-I pathway.
Conclusions:
- MHV employs a mechanism to evade IFN-I antiviral effects by delaying ISG induction through an alternative pathway.
- The virus appears to interfere with early ISG induction, potentially by modulating IRF-3 function.
- Understanding this evasion strategy is critical for developing effective antiviral therapies against coronaviruses.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release
Experimental RNAi

